Authors:
Doolittle, ND
Muldoon, LL
Brummett, RE
Tyson, RM
Lacy, C
Bubalo, JS
Kraemer, DF
Heinrich, MC
Henry, JA
Neuwelt, EA
Citation: Nd. Doolittle et al., Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors, CLIN CANC R, 7(3), 2001, pp. 493-500
Authors:
Remsen, LG
Marquez, C
Garcia, R
Thrun, LA
Neuwelt, EA
Citation: Lg. Remsen et al., Efficacy after sequencing of brain radiotherapy and enhanced antibody targeted chemotherapy delivery in a rodent human lung cancer brain xenograft model, INT J RAD O, 51(4), 2001, pp. 1045-1049
Authors:
Osztie, E
Varallyay, P
Doolittle, ND
Lacy, C
Jones, G
Nickolson, HS
Neuwelt, EA
Citation: E. Osztie et al., Combined intraarterial carboplatin, intraarterial etoposide phosphate, andIV cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children, AM J NEUROR, 22(5), 2001, pp. 818-823
Authors:
Kraemer, DF
Fortin, D
Doolittle, ND
Neuwelt, EA
Citation: Df. Kraemer et al., Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (Human non-acquired immunodeficiency syndrome) and survival, NEUROSURGER, 48(5), 2001, pp. 1033-1040
Authors:
Muldoon, LL
Walker-Rosenfeld, SL
Hale, C
Purcell, SE
Bennett, LC
Neuwelt, EA
Citation: Ll. Muldoon et al., Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants, J PHARM EXP, 296(3), 2001, pp. 797-805
Authors:
Neuwelt, EA
Pagel, MA
Hasler, BP
Deloughery, TG
Muldoon, LL
Citation: Ea. Neuwelt et al., Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administrationof alkylators, with or without glutathione depletion in a rat model, CANCER RES, 61(21), 2001, pp. 7868-7874
Authors:
Muldoon, LL
Pagel, MA
Kroll, RA
Brummett, RE
Doolittle, ND
Zuhowski, EG
Egorin, MJ
Neuwelt, EA
Citation: Ll. Muldoon et al., Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity, CLIN CANC R, 6(1), 2000, pp. 309-315
Citation: Ea. Neuwelt, Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry of sodium borocaptate in patients with gliomas - Comment, NEUROSURGER, 47(3), 2000, pp. 622-622
Citation: Ea. Neuwelt, Improved survival after boron neutron capture therapy of brain tumors by cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine - Comment, NEUROSURGER, 47(1), 2000, pp. 197-198
Authors:
Fortin, D
McCormick, CI
Remsen, LG
Nixon, R
Neuwelt, EA
Citation: D. Fortin et al., Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modificationto enhance delivery, using propofol for general anesthesia, in a rat model, NEUROSURGER, 47(1), 2000, pp. 199-207
Authors:
Remsen, LG
Trail, PA
Hellstrom, I
Hellstrom, KE
Neuwelt, EA
Citation: Lg. Remsen et al., Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model, NEUROSURGER, 46(3), 2000, pp. 704-709
Authors:
McAllister, LD
Doolittle, ND
Guastadisegni, PE
Kraemer, DF
Lacy, CA
Crossen, JR
Neuwelt, EA
Citation: Ld. Mcallister et al., Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma, NEUROSURGER, 46(1), 2000, pp. 51-60
Authors:
Doolittle, ND
Miner, ME
Hall, WA
Siegal, T
Hanson, EJ
Osztie, E
McAllister, LD
Bubalo, JS
Kraemer, DF
Fortin, D
Nixon, R
Muldoon, LL
Neuwelt, EA
Citation: Nd. Doolittle et al., Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors, CANCER, 88(3), 2000, pp. 637-647
Authors:
Guastadisegni, PE
Simon, JL
Neuwelt, J
Camicioli, R
Mueller, R
Neuwelt, EA
Citation: Pe. Guastadisegni et al., Innovative intergenerational prevention programming for older adults and adolescents, J AM GER SO, 48(1), 2000, pp. 105-106
Authors:
Muldoon, LL
Pagel, MA
Kroll, RA
Roman-Goldstein, S
Jones, RS
Neuwelt, EA
Citation: Ll. Muldoon et al., A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery, AM J NEUROR, 20(2), 1999, pp. 217-222
Authors:
Fortin, D
McAllister, LD
Nesbit, G
Doolittle, ND
Miner, M
Hanson, EJ
Neuwelt, EA
Citation: D. Fortin et al., Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruptionin the vertebral artery, AM J NEUROR, 20(10), 1999, pp. 1794-1802
Authors:
Neuwelt, EA
Abbott, NJ
Drewes, L
Smith, QR
Couraud, PO
Chiocca, EA
Audus, KL
Greig, NH
Doolittle, ND
Citation: Ea. Neuwelt et al., Cerebrovascular biology and the various neural barriers: Challenges and future directions, NEUROSURGER, 44(3), 1999, pp. 604-608
Citation: Ea. Neuwelt et Ld. Mcallister, Intra-arterial Cereport (RMP-7) and carboplatin: A dose escalation study for recurrent malignant gliomas - Comment, NEUROSURGER, 44(2), 1999, pp. 278-279
Citation: Ea. Neuwelt et Ra. Kroll, Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7) - Comment, NEUROSURGER, 44(2), 1999, pp. 359-360
Authors:
Remsen, LG
Pagel, MA
McCormick, CI
Fiamengo, SA
Sexton, G
Neuwelt, EA
Citation: Lg. Remsen et al., The influence of anesthetic choice, Paco(2), and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts, ANESTH ANAL, 88(3), 1999, pp. 559-567
Authors:
Lauer, AK
Wobig, JL
Shults, WT
Neuwelt, EA
Wilson, MW
Citation: Ak. Lauer et al., Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy, AM J OPHTH, 127(2), 1999, pp. 230-233